Fabry Disease Treatment Market Share

Statistics for the 2023 & 2024 Fabry Disease Treatment market share, created by Mordor Intelligence™ Industry Reports. Fabry Disease Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Genetic Disorder Drugs Research Fabry Disease Treatment Market Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Fabry Disease Treatment Industry

The Fabry disease treatment market is consolidated in nature due to the presence of a few major players operating globally and regionally. A few of the major companies in the market are Sanofi (Genzyme Corporation), Takeda Pharmaceutical Company Limited, Amicus Therapeutics, Inc, ISU ABXIS, JCR Pharmaceuticals Co., Ltd., Protalix BioTherapeutics, among others.

Fabry Disease Treatment Market Leaders

  1. Sanofi (Genzyme Corporation)

  2. Takeda Pharmaceutical Company Limited

  3. Amicus Therapeutics, Inc

  4. ISU ABXIS

  5. JCR Pharmaceuticals Co., Ltd.

*Disclaimer: Major Players sorted in no particular order

Fabry Disease Treatment Market Concentration

Fabry Disease Treatment Market Report Snapshots

Fabry Disease Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)